Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Here are five points:
1. B. Riley researchers estimate Mazor will see second quarter 2018 earnings of $0.13 EPS; third quarter 2018 earnings of $0.12 EPS; and fourth quarter 2018 earnings of $0.07 EPS.
2. The firm has a "neutral" rating on Mazor with a $25 price objective.
3. Mazor has a 52-week low of $9.16 and 52-week high of $26.55.
4. The company's 50-day moving average is $22.62, with a 200-day moving average of $22.74.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies